Issue 26/2014 - Dow showcases innovative solutions for pharmaceutical excipients

Dow showcases innovative solutions for pharmaceutical excipients

Recently, at the 2014 International Pharmaceutical Preparations and Excipients Development Forum and the 4th China Pharmaceutical Excipients Festival, Dow Chemical (Dow) jointly unveiled its latest series of innovative solutions in the field of pharmaceutical excipients, such as pharmaceutical ion exchange resins, cellulose ether series products, and leading research and development achievements
such as polyethylene glycol and polyethylene glycol methyl ether.

Dow Water Treatment & Process Solutions shares information about the use of ion exchange resins in novel drug delivery systems, including Dow's unique AMBERLITETM IRP and DUOLITETM pharmaceutical ion exchange resins
.
The excellent performance of this series makes it an important ingredient in oral formulations, making the process of taking the medication smoother and more comfortable, thereby effectively improving the drug experience
.

Dow Pharmaceuticals and Food Solutions shared the results of research on the stability of hypromellose batch-to-batch on the stability of sustained-release formulations, and introduced the impact of Dow MeduoxiuTM CR (Sustained-Release Specification) grade on the consistency evaluation of
generic drugs.
Dow Chemical's MeiduoxiuTM VLV (Very Low Viscosity Specification) pharmaceutical excipients are suitable for coating granulation of moist and heat-sensitive drugs and the encapsulation of small pill isolation gowns, which is an ideal solution
for room temperature coating with high efficiency, low cost and high quality.

Dow Industrial Solutions showcased two of Dow Chemical's star products, CARBOWAXTM SENTRYTM polyethylene glycol and polyethylene glycol methyl ether
.
（Coco）